Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update
Data(s) |
17/03/2014
|
---|---|
Resumo |
• Guidelines reflecting contemporary clinical practice in the management of Buruli ulcer (<i>Mycobacterium ulceran</i>s infection) in Australia were published in 2007. <br /><br />• Management has continued to evolve, as new evidence has become available from randomised trials, case series and increasing clinical experience with oral antibiotic therapy. <br /><br />• Therefore, guidelines on the diagnosis, treatment and prevention of Buruli ulcer in Australia have been updated. They include guidance on the new role of antibiotics as first-line therapy; the shortened duration of antibiotic treatment and the use of all-oral antibiotic regimens; the continued importance, timing and role of surgery; the recognition and management of paradoxical reactions during antibiotic treatment; and updates on the prevention of disease. |
Identificador | |
Idioma(s) |
eng |
Publicador |
AMPCo |
Relação |
http://dro.deakin.edu.au/eserv/DU:30086596/athan-treatmentand-2014.pdf http://dx.doi.org/10.5694/mja13.11331 |
Direitos |
2014, AMPCo |
Palavras-Chave | #anti-bacterial agents #Australia #Buruli ulcer #debridement #drug therapy, combination #hot temperature #humans #Mycobacterium ulcerans #practice guidelines as topic #rifampin #streptomycin |
Tipo |
Journal Article |